AgomAb Therapeutics Ownership & Insider Activity

AgomAb Therapeutics (AGMB) institutional and insider ownership, recent insider transactions and ownership breakdown.

Institutional investors hold 10.6%. Over the past 90 days, insiders made 4 purchases worth $311K.

Shares Outstanding

49.248M

Shares Float

40.755M

Institutional Shares Held

5.231M

Institutional % Held

10.6%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

$311K total

Sales (90d)

Net Activity

Net Buying

Net Value (90d)

$311K

AgomAb Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 8, 2026	David Epstein	DIRECTOR	BUY	5.000K	$8.90	$45K
Oct 6, 2026	Victor Thadee Pierre Kemula	CHIEF FINANCIAL OFFICER	BUY	10.000K	$8.59	$86K
Oct 5, 2026	David Epstein	DIRECTOR	BUY	10.000K	$8.63	$86K
Oct 5, 2026	Jasper Tim Knotnerus	CHIEF EXECUTIVE OFFICER	BUY	11.000K	$8.58	$94K